Abstract:Background: Tobacco smoking is a well-established bladder cancer risk factor, and a rich source of chemical carcinogens and reactive oxygen species that can induce a variety of DNA damage to urothelial cells. Selected genetic variants in a few DNA repair genes have been shown to modify both bladder cancer risk and the effect of smoking on this risk. In this study, we conducted genotypic analyses using a set of 571 tagSNPs that comprehensively captured common genetic variation in 27 DNA repair genes corresponding to four DNA repair pathways: base excision repair (BER), nucleotide excision repair (NER), non-homologous end-joining (NHEJ), and homologous recombination repair (HHR). Methods: We used data and samples from 757 cases and 770 controls enrolled in the Los Angeles County Bladder Cancer Study and 545 cases and 537 controls enrolled in the Shanghai Bladder Cancer Study, for a total of 1,302 cases and 1,307 controls. Genotypic data on all selected tagSNPs was obtained using the Golden Gate Assay (Illumina, Inc). Odds ratios (ORs) and 95% confidence intervals (CIs) for bladder cancer associated with each tagSNP were calculated using conditional logistic regression models and corrected for multiple testing for all SNPs within each gene using pACT, and for different genes within each pathway and across all pathways using the Bonferroni method. The interaction effect between tagSNPs and smoking on bladder cancer risk were tested using conditional logistic regression models and corrected within each gene, pathway and across pathways using the Bonferroni method. Results: We observed an association between a SNP in the BER pathway (POLB gene; rs7832529; OR = 1.46; 95% CI = 1.17–1.81) that remained statistically significant following correction for all (11) SNPs in POLB (pACT p = 0.006) and further correction for all (7) genes in the BER pathway (p = 0.004), but not after further correction for all pathways considered (4) (p = 0.172). We also observed evidence of gene x years of smoking interactions for a SNP in the NER pathway (XPC gene; rs17038942) that remained statistically significant following correction for all (24) SNPs in XPC (interaction p = 0.003), further correction for all (8) genes within NER (interaction p = 0.003) and further correction for all pathways considered (interaction p = 0.011). Similar findings were observed for pack-years of smoking, where an interaction was also observed for a SNP in the NHEJ (XRCC6 gene, rs4239895)(interaction p for gene = 0.007; interaction p for pathway = 0.044; interaction p for all pathways = 0.178). Conclusions: Our findings highlight a role in bladder carcinogenesis for genes that play key roles in repair of oxidative damage (POLB, XRCC6 and XPC) and one gene that also plays a role in repair of bulky adducts (XPC). Citation Information: Cancer Prev Res 2011;4(10 Suppl):A1.

Smoking, Subdivided Blood Lipids and Bladder Cancer: A Multivariable and Mediation Mendelian Randomization Study

Causal Association of Smoking, Blood Lipids, and Bladder Cancer: Insights from a Multivariable and Mediation Mendelian Randomization Investigation.

Blood lipids, lipid-regulatory medications, and risk of bladder cancer: a Mendelian randomization study

Exploring the Cross-Cancer Effect of Smoking and Its Fingerprints in Blood DNA Methylation on Multiple Cancers: A Mendelian Randomization Study

The causal association between smoking, alcohol consumption and risk of bladder cancer: A univariable and multivariable Mendelian randomization study

Smoking and heart failure: a Mendelian randomization and mediation analysis

Mendelian Randomization Analysis Revealed Pan-Effect of Smoking Instead of Alcohol Consumption on 24 Gastrointestinal Diseases

Unveiling the association between HMG-CoA reductase inhibitors and bladder cancer: a comprehensive analysis using Mendelian randomization, animal models, and transcriptomics

Differential DNA methylation in blood as a mediator of the association between cigarette smoking and bladder cancer risk among postmenopausal women

Smoking and coronary artery disease risk in patients with diabetes: A Mendelian randomization study

A Mendelian randomization study on the causal effects of cigarette smoking on liver fibrosis and cirrhosis

Higher genetically predicted triglyceride level increases the bladder cancer risk independent of LDL and HDL levels

The causal relationship between metabolic factors, drinking, smoking and intrahepatic cholangiocarcinoma: a Mendelian randomization study

Abstract A1: Comprehensive Analyses of DNA Repair Pathways, Smoking, and Bladder Cancer Risk in Los Angeles and Shanghai

An Integrative Approach for Identification of Smoking-Related Genes Involving Bladder Cancer.

The causal association between smoking, alcohol consumption and risk of upper urinary calculi: insights from a Mendelian randomization study

High-order Interactions among Genetic Variants in DNA Base Excision Repair Pathway Genes and Smoking in Bladder Cancer Susceptibility.

Effect of smoking-related features and 731 immune cell phenotypes on esophageal cancer: a two-sample and mediated Mendelian randomized study

A prospective study of smoking-related white blood cell DNA methylation markers and risk of bladder cancer

The causal relationship between smoking, alcohol consumption, and renal clear cell carcinoma: a Mendelian randomization study

Mediating Effects of Lipids on the Association Between Smoking and Coronary Artery Disease Risk among Chinese